The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

“Prostate cancer patients with life expectancies of less than five or 10 years were being subjected to treatments that can ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

Routt County resident James Onufrak knew his dad was diagnosed with prostate cancer at age 61, so he worked with his own ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a ...

Listen to a short summary Read by Guy R. Your browser does not support the audio element.Talking about "cancer" can make ...

Evidence suggests that combining metformin with standard of care could increase survival and offer other benefits to patients with high-volume disease.

ANDROGEN deprivation therapy (ADT) has been the cornerstone of treatment for advanced castration-sensitive prostate cancer ...